Martingale Asset Management L P Biomarin Pharmaceutical Inc Transaction History

Martingale Asset Management L P

$4.27 Billion
Q3 2024

A detailed history of Martingale Asset Management L P transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Martingale Asset Management L P holds 50,878 shares of BMRN stock, worth $3.39 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

50,878

Previous 57,938 12.19%

Holding current value

$3.39 Million

Previous $4.77 Million 25.03%

% of portfolio

0.08%

Previous 0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $487,281 - $662,510	-7,060 Reduced 12.19%	50,878 $3.58 Million
Q2 2024 Aug 12, 2024	SELL	$74.43 - $92.22 $719,440 - $891,398	-9,666 Reduced 14.3%	57,938 $4.77 Million
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $389,716 - $460,350	-4,650 Reduced 6.44%	67,604 $5.9 Million
Q4 2023 Feb 12, 2024	SELL	$76.22 - $98.51 $700,385 - $905,208	-9,189 Reduced 11.28%	72,254 $6.97 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $761,291 - $845,501	-8,949 Reduced 9.9%	81,443 $7.21 Million
Q2 2023 Aug 11, 2023	SELL	$86.68 - $100.3 $469,545 - $543,325	-5,417 Reduced 5.65%	90,392 $7.84 Million
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $434,225 - $580,369	4,949 Added 5.45%	95,809 $9.32 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $580,106 - $778,659	7,168 Added 8.56%	90,860 $9.4 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $474,802 - $560,216	5,779 Added 7.42%	83,692 $7.1 Million
Q2 2022 Aug 11, 2022	BUY	$71.48 - $86.85 $1.6 Million - $1.95 Million	22,447 Added 40.47%	77,913 $6.46 Million
Q1 2022 May 12, 2022	BUY	$74.28 - $92.69 $1.1 Million - $1.37 Million	14,833 Added 36.5%	55,466 $4.28 Million
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $1.24 Million - $1.58 Million	17,300 Added 74.14%	40,633 $3.59 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $1.74 Million - $1.99 Million	23,333 New	23,333 $1.8 Million
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $823,965 - $925,228	-10,912 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $815,453 - $989,609	10,912 New	10,912 $823,000
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $2.86 Million - $5.21 Million	-39,763 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$79.55 - $124.22 $3.16 Million - $4.94 Million	39,763 New	39,763 $4.9 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Biomarin Pharmaceutical Inc Transaction History